Christopher Gilfillan

Adjuct Clinical Professor

MONASH UNIVERSITY

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Gilfillan is an Adjunct Clinical Professor at Monash University, Australia. His research interests focus on metabolic syndrome, type 2 diabetes management, and muscle mass assessment, as demonstrated in his recent articles. He has contributed significantly to studies investigating dietary intake, physical activity, and the use of artificial intelligence in diabetes screening. His work spans both clinical and epidemiological perspectives in diabetes and related health conditions.

Articles (9)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Bernard Champion

Macquarie University

AUSTRALIA

View details

Nora Shields

AUSTRALIA

View details

Judi Porter

MONASH UNIVERSITY

AUSTRALIA

View details

SANTIAGO TOFÉ

Profesor Asociado

University of the Balearic Islands

SPAIN

View details

Tian Yu Goh

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Gilfillan

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Understanding the hidden epidemic of metabolic syndrome in people accessing community rehabilitation: a cross-sectional study of physical activity, dietary intake, and health literacy

Physician-Authored Feedback in a Type 2 Diabetes Self-management App: Acceptability Study

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women.

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Collaborators (5)

Bernard Champion

Nora Shields

Judi Porter

SANTIAGO TOFÉ

Tian Yu Goh

Make your next move.

Christopher Gilfillan

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Understanding the hidden epidemic of metabolic syndrome in people accessing community rehabilitation: a cross-sectional study of physical activity, dietary intake, and health literacy

Physician-Authored Feedback in a Type 2 Diabetes Self-management App: Acceptability Study

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women.

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Real-world﻿ artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Collaborators (5)

Bernard Champion

Nora Shields

Judi Porter

SANTIAGO TOFÉ

Tian Yu Goh

Make your next move.

Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.